8-K: Orgenesis Inc. to be Delisted from Nasdaq, Director Resigns

Orgenesis Inc. will be delisted from the Nasdaq and a director has resigned, effective immediately.

Summary

• Orgenesis Inc. received notification from Nasdaq on October 17, 2024, that it plans to file a Form 25 to delist the company's common stock.
• The delisting will become effective 10 days after the Form 25 is filed.
• The company's common stock will be deregistered under Section 12(b) of the Exchange Act 90 days after the Form 25 filing, or sooner if the SEC determines.
• The company's stock began trading on the OTCQX on October 21, 2024.
• Jagannathan Bhalaji resigned as a director of Orgenesis Inc. on December 24, 2024, for personal reasons, not due to any disagreements with the company.

Sentiment

Score: 3

Explanation: The delisting from Nasdaq and the director's resignation are negative events, indicating potential instability and reduced investor confidence.

Negatives

• The company's common stock will be delisted from Nasdaq.
• A director has resigned from the board.

Risks

• Delisting from Nasdaq could negatively impact investor confidence and the company's stock price.
• The resignation of a director could indicate internal issues or instability within the company.

Future Outlook

The company's common stock will remain registered under Section 12(g) of the Exchange Act after deregistration under Section 12(b).

Management Comments

• Mr. Bhalaji's resignation was not the result of any disagreement with the Company, or its management on any matter relating to the Company's operations, policies or practices.

Industry Context

Delistings can occur for various reasons, including failure to meet listing requirements, and can impact a company's access to capital and investor perception.

Comparison to Industry Standards

• Delisting from a major exchange like Nasdaq is generally viewed negatively by investors, as it can reduce liquidity and visibility.
• Companies that move to the OTC markets often face challenges in attracting institutional investors and maintaining a stable share price.
• Director resignations, especially when not due to disagreements, can raise questions about the company's internal dynamics and future direction.

Management Changes

Stakeholder Impact

• Shareholders may experience a decrease in the value of their investment due to the delisting.
• Employees may be concerned about the company's future stability.
• The company's reputation may be negatively impacted.

Next Steps

• Nasdaq will file a Form 25 with the SEC to delist the company's common stock.
• The delisting will become effective 10 days after the Form 25 is filed.
• The company's common stock will be deregistered under Section 12(b) of the Exchange Act 90 days after the Form 25 filing, or sooner if the SEC determines.

Key Dates

Keywords

delisting, Nasdaq, OTCQX, director resignation, Form 25, Orgenesis Inc., stock market